Health Care Equipment & Services

Zimmer Biomet shares Q3 earnings beat but faces muted market response; learn how the company plans to navigate growth gaps, competition, and regulatory pressures in its upcoming Jefferies Healthcare Conference presentation.

Explore Straumann Holding AG’s Q1 2024 surge: record revenue, cost‑saving wins, ESG goals and value‑based pricing boosting investor confidence.

Sonova Holding AG’s latest market performance shows a steady P/E and robust margins, while its strategic focus on reimbursement, supply‑chain resilience, and AI‑enhanced hearing tech positions it well for future growth.

Dexcom’s CGM tech faces legal scrutiny and price‑target cuts; learn how litigation, margin pressure, and market gaps shape its future.

Smith & Nepphew’s modest share drop mirrors market uncertainty, but the firm’s leading role in innovative silk wound‑dressings—backed by strong clinical data and regulatory approvals—positions it for long‑term relevance in next‑generation wound‑care.

Siemens Healthineers reports a 3.4 % revenue dip driven by US tariff hikes, yet keeps dividends steady; investors await next‑quarter earnings and a cautious 2025 profit outlook.

Fresenius SE & Co KGaA’s Q4 2025 outlook: modest EPS lift, 5‑7% revenue growth, and an upward‑revised EBIT margin driven by cost control and digital gains.

UnitedHealth Group’s Q3 earnings beat expectations amid DOJ scrutiny of Medicare billing and a price‑increase plan, yet share buy‑backs show investor confidence in its future growth.

Fresenius Medical Care’s Q3 2025 earnings show a 9.4% income boost from cost cuts and modest U.S. growth, but rising regulatory risks and R&D cuts threaten long‑term gains.

Philips Q3 earnings: modest revenue growth, rising EBITA margins and a strong push into AI‑driven imaging, cloud monitoring and digital health to meet payer value‑based models while navigating supply‑chain and cyber‑security challenges.